IP and the Generics Industry

Join SMi's IP and the Generics Industry masterclass taking place on the 8 July in London, to navigate through the complicated landscape of intellectual property and generics.


Intellectual Property (IP) lies at the very heart of the generics industry and it is vital to understand why the subject is so important. It represents the front line in the battles between originators , who want to protect their inventions for as long as possible, and the generic firms that want to copy their products as soon as possible. A good understanding of the topic is vital for anyone working in either originator or generic companies as, without it, there is a risk of making very expensive mistakes.

This masterclass hosted by Interpharm Consultancy will help you to navigate the complicated landscape of intellectual property and generics. IP issues can affect both the exclusivity period of an originator’s product on the one hand and the development, registration and launch of a generic copy on the other. Either way, making mistakes due to a lack of knowledge can work out very expensive.Generic companies are also increasingly aggressive in their use of patents against each other to gain advantages. Whichever side of this boundary you stand, it is vital to have a good understanding of the basic issues, which this half day seminar is designed to provide.